Description
Each Allo•PAX provides 3 grams of Levocetirizine dihydrochloride, 3 grams Loratadine USP, and 54 grams of Base. The resulting mixture is intended for transdermal use.
Allopax
FDA Label NDC 69817-0201
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Pharmagenetico Llc for the product Allopax (NDC 69817-0201). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding description, other, instructions for use, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Other
For Prescription Use Only
Distributed by:
PharmaGenetico LLC
San Antonio, TX 78257
Instructions For Use
Allopax Insert (Allopaxinsert)
Package Label.Principal Display Panel
* Please review the disclaimer below.
